The FGB Gene Afibrinogenemia Congenital Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at detecting mutations in the FGB gene, which are responsible for congenital afibrinogenemia. This rare genetic disorder is characterized by the complete absence or extremely low levels of fibrinogen, a critical protein necessary for blood clotting. Individuals with this condition are at a heightened risk of bleeding complications, which can range from mild to severe.
The test is conducted through a detailed analysis of the patient's DNA, extracted from a blood sample, to identify any genetic alterations in the FGB gene that may lead to the disorder. The results from this test can provide essential information for the accurate diagnosis, management, and treatment of congenital afibrinogenemia, allowing for personalized medical care and preventive measures against severe bleeding episodes.
Priced at 4400 AED, the FGB Gene Afibrinogenemia Congenital Genetic Test is an investment in health, offering peace of mind for individuals with a family history of the condition or those exhibiting symptoms suggestive of a bleeding disorder. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test represents a crucial step towards understanding and managing congenital afibrinogenemia effectively.
The FGG Gene Afibrinogenemia Congenital Genetic Test is a specialized diagnostic procedure designed to identify mutations in the FGG gene, which are responsible for congenital afibrinogenemia. Congenital afibrinogenemia is a rare genetic disorder characterized by the complete absence of fibrinogen, a protein essential for blood clotting. This condition can lead to severe bleeding complications from an early age. The test involves analyzing the patient's DNA to detect any genetic alterations in the FGG gene that could lead to the disorder.
This test is particularly important for individuals with a family history of bleeding disorders or for those who have experienced unexplained bleeding episodes. Early diagnosis through genetic testing can facilitate timely management and treatment strategies, potentially reducing the risk of severe bleeding events.
The FGG Gene Afibrinogenemia Congenital Genetic Test is available at DNA Labs UAE, a leading facility in genetic diagnostics. The test is priced at 4400 AED. DNA Labs UAE employs cutting-edge technology and highly skilled professionals to ensure accurate and reliable results, providing essential information for the management of congenital afibrinogenemia and related bleeding disorders.
The "BTK Gene Agammaglobulinemia and Isolated Hormone Deficiency Genetic Test" is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the BTK gene, which are associated with X-linked agammaglobulinemia (XLA) and potentially isolated hormone deficiencies. XLA is a primary immunodeficiency disorder characterized by a severe reduction in all types of gamma globulins, including antibodies, leading to an increased susceptibility to infections. The BTK gene plays a crucial role in the development and functioning of B cells, which are essential for the production of antibodies. Mutations in this gene can disrupt the normal production and function of B cells, resulting in the symptoms observed in individuals with XLA.
This genetic test is crucial for early diagnosis and management of the condition, allowing for targeted treatment strategies to prevent severe infections and improve quality of life. It involves collecting a DNA sample, typically through a blood draw, and analyzing the BTK gene for specific mutations. The test is priced at 4400 AED and is conducted at DNA Labs UAE, a facility known for its advanced genetic testing capabilities and adherence to high standards of accuracy and reliability. Early diagnosis through this test can significantly impact the management of individuals with XLA, enabling healthcare providers to implement appropriate immunoglobulin replacement therapies and other interventions to mitigate the effects of the condition.
The "BTK Gene Agammaglobulinemia type 1 X-linked Genetic Test" is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the BTK (Bruton's tyrosine kinase) gene. This gene is crucial for the normal development of B cells, which are a type of white blood cell essential for producing antibodies. Mutations in the BTK gene lead to X-linked agammaglobulinemia (XLA), a rare genetic disorder that significantly impairs the body's immune system, making individuals more susceptible to infections.
XLA is characterized by very low levels of immunoglobulins (antibodies) in the blood, which are crucial for fighting infections. Symptoms usually manifest in early childhood and can include recurrent bacterial infections, such as otitis media, pneumonia, and sinusitis, among others. Given its genetic basis, the condition predominantly affects males, with females being carriers of the mutated gene.
The test provided by DNA Labs UAE involves collecting a DNA sample, typically through a blood draw, and analyzing it for mutations in the BTK gene. It is a critical tool for confirming a diagnosis of X-linked agammaglobulinemia, especially in young males presenting with recurrent infections and low immunoglobulin levels. Early diagnosis through genetic testing can lead to timely management and treatment strategies, significantly improving the quality of life for affected individuals.
The cost of the test is 4400 AED, reflecting the specialized nature of the genetic analysis and the comprehensive insight it offers into the patient's condition. This test is not only pivotal for diagnosing affected individuals but also for genetic counseling of families, offering them information about the inheritance patterns, potential risks for future children, and considerations for family planning.
The IGLL1 gene plays a critical role in the development and function of B cells, which are essential components of the adaptive immune system. Mutations in the IGLL1 gene can lead to a condition known as agammaglobulinemia type 2, a rare form of immunodeficiency characterized by an almost complete lack of immunoglobulins or antibodies in the blood. This condition is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene (one from each parent) to be affected.
The genetic test for IGLL1 gene agammaglobulinemia type 2 is a specialized diagnostic tool used to identify mutations in the IGLL1 gene. This test is crucial for confirming the diagnosis of agammaglobulinemia type 2, enabling healthcare providers to offer appropriate treatment and management strategies for affected individuals. Early diagnosis and treatment are vital for preventing recurrent infections and other complications associated with this condition.
DNA Labs UAE offers this genetic test, providing a reliable service for detecting mutations in the IGLL1 gene. The cost of the test is 4400 AED. Conducting the test in a reputable laboratory like DNA Labs UAE ensures accuracy and reliability of the results, which are essential for making informed medical decisions and providing the best care for patients with agammaglobulinemia type 2.
The CD79A gene plays a crucial role in the immune system's ability to fight infections. Mutations in this gene can lead to a condition known as Agammaglobulinemia type 3, an autosomal recessive disorder. This rare genetic condition is characterized by an almost complete lack of immunoglobulins or antibodies in the blood, making individuals highly susceptible to infections.
To diagnose this condition, a genetic test focusing on the CD79A gene can be conducted. This test is crucial for identifying mutations in the CD79A gene that are responsible for Agammaglobulinemia type 3. Early diagnosis through genetic testing allows for timely intervention and management of the condition, helping to prevent severe infections and improve quality of life for affected individuals.
In the United Arab Emirates, DNA Labs UAE offers this specialized genetic test. The cost of the test is 4400 AED. DNA Labs UAE is equipped with state-of-the-art technology to provide accurate and reliable genetic testing services, ensuring that individuals and families receive the crucial information needed for managing Agammaglobulinemia type 3 and related conditions.
The BLNK gene Agammaglobulinemia type 4 autosomal recessive genetic test is a specialized diagnostic tool used to identify mutations in the BLNK gene, which are linked to a rare form of Agammaglobulinemia. This condition, characterized by an impaired immune system due to the lack of immunoglobulins (antibodies), can lead to frequent infections and other immune-related issues. As an autosomal recessive disorder, a child must inherit two copies of the mutated gene, one from each parent, to be affected.
This specific genetic test, conducted at DNA Labs UAE, is crucial for early detection and management of the condition. It involves analyzing the patient's DNA to look for specific mutations in the BLNK gene that are responsible for Agammaglobulinemia type 4. Early diagnosis through this test can significantly improve the quality of life for affected individuals by enabling timely and appropriate treatments to manage symptoms and prevent complications.
The cost of the BLNK gene Agammaglobulinemia type 4 autosomal recessive genetic test at DNA Labs UAE is 4400 AED. This investment in health allows for a comprehensive understanding of the genetic basis of the condition, facilitating informed decisions about care and management for those affected and their families.
The LRRC8A gene plays a crucial role in the immune system's ability to produce antibodies. Mutations in this gene can lead to a condition known as Agammaglobulinemia type 5, a rare autosomal recessive disorder characterized by an almost complete lack of immunoglobulins (antibodies) in the blood. This condition makes individuals highly susceptible to infections. The genetic test for Agammaglobulinemia type 5 associated with the LRRC8A gene mutation is a critical diagnostic tool for identifying this condition.
Performed at DNA Labs UAE, this genetic test is priced at 4400 AED. It involves analyzing the patient's DNA to detect mutations in the LRRC8A gene that are responsible for the disease. Early diagnosis through this test can lead to timely management and treatment strategies, significantly improving the quality of life for affected individuals. This test is recommended for individuals with a family history of immunodeficiency disorders or those presenting with symptoms consistent with agammaglobulinemia.
The CD79B gene plays a critical role in the development and function of B cells, which are essential for the production of antibodies in the immune system. Mutations in the CD79B gene can lead to a rare immunodeficiency disorder known as Agammaglobulinemia type 6, characterized by an almost complete lack of B cells and, consequently, very low levels of immunoglobulins (antibodies) in the blood. This condition is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
To diagnose this condition, genetic testing of the CD79B gene can be conducted. DNA Labs UAE offers a comprehensive genetic test for Agammaglobulinemia type 6, targeting mutations in the CD79B gene. The test is priced at 4400 AED and is performed using advanced genetic sequencing technologies to accurately identify mutations in the gene. This test is crucial for the early diagnosis and management of affected individuals, allowing for appropriate treatment strategies to be implemented, such as immunoglobulin replacement therapy, to improve the quality of life and reduce the risk of infections.
By identifying carriers of the gene mutation, the test also provides valuable information for family planning purposes to at-risk couples. DNA Labs UAE ensures confidentiality and accuracy in the testing process, with results being used to guide clinical decisions and support affected families.
The PIK3R1 Gene Agammaglobulinemia Type 7 Autosomal Recessive Genetic Test is a specialized diagnostic tool used to identify mutations in the PIK3R1 gene, which are linked to a rare form of agammaglobulinemia, known as type 7. This condition is an autosomal recessive disorder, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to develop the disease. Agammaglobulinemia affects the body's ability to properly produce immunoglobulins (antibodies), leading to a significantly weakened immune system and a heightened susceptibility to infections.
The test, available at DNA Labs UAE, is designed to provide a definitive diagnosis by analyzing the patient's DNA for specific mutations in the PIK3R1 gene. This is crucial for the early detection of the disorder, allowing for timely intervention and management strategies to mitigate the risk of severe infections and other complications associated with the condition.
Priced at 4400 AED, the test is a vital resource for individuals with a family history of agammaglobulinemia or those exhibiting symptoms consistent with immune deficiencies. By confirming the presence of PIK3R1 gene mutations, the test not only aids in the diagnosis but also helps in guiding treatment decisions and genetic counseling for affected families.
